{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:49Z","timestamp":1791938929041,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["P30 AG072946, R01 NS118584, RF1 AG082339, P01 AG078116, and R01 AG076932"],"award-info":[{"award-number":["P30 AG072946, R01 NS118584, RF1 AG082339, P01 AG078116, and R01 AG076932"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03100-8","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:42:18Z","timestamp":1791920538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer\u2019s Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain"],"prefix":"10.1007","volume":"152","author":[{"given":"Benjamin J.","family":"Cushing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Shahidehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Abner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Jicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna M.","family":"Neltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline K.","family":"Breig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailen L.","family":"Teodorescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Neltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Pinar","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"3100_CR1","unstructured":"National Alzheimer\u2019s Coordinating Center. The NACC neuropathology data form\u2014version 11. https:\/\/files.alz.washington.edu\/documentation\/np11-form.pdf. Accessed 23 May 2026"},{"key":"3100_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000218121","author":"CH Adler","year":"2026","unstructured":"Adler CH, Janarthanam C, Serrano GE, Anantharam V, Beach TG, Shill H et al (2026) Alpha-synuclein seed amplification assay in CSF, skin, and submandibular gland from incidental Lewy body disease and Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/wnl.0000000000218121","journal-title":"Neurology"},{"key":"3100_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/mds.27619","volume":"34","author":"F Ali","year":"2019","unstructured":"Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY et al (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord 34:1144\u20131153. https:\/\/doi.org\/10.1002\/mds.27619","journal-title":"Mov Disord"},{"key":"3100_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70575","author":"FC Almeida","year":"2025","unstructured":"Almeida FC, Marx GA, Rohde SK, Gonzales MM, Maldonado\u2010D\u00edaz C, Hiya S et al (2025) Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.70575","journal-title":"Alzheimers Dement"},{"key":"3100_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107109","volume":"127","author":"N Badihian","year":"2024","unstructured":"Badihian N, Tosakulwong N, Weigand SD, Ali F, Clark HM, Stierwalt J et al (2024) Relationships between regional burden of tau pathology and age at death and disease duration in PSP. Parkinsonism Relat Disord 127:107109. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107109","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-026-00899-5","author":"E Bayram","year":"2026","unstructured":"Bayram E, Carter DJ, Aslam S, Forbes E, Holden SK (2026) Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies. Biol Sex Differ. https:\/\/doi.org\/10.1186\/s13293-026-00899-5","journal-title":"Biol Sex Differ"},{"key":"3100_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/jad-180141","volume":"64","author":"CR Beam","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M (2018) Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease. J Alzheimers Dis 64:1077\u20131083. https:\/\/doi.org\/10.3233\/jad-180141","journal-title":"J Alzheimers Dis"},{"key":"3100_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","volume":"21","author":"DL Beekly","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J et al (2007) The National Alzheimer\u2019s Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord 21:249\u2013258. https:\/\/doi.org\/10.1097\/WAD.0b013e318142774e","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3100_CR9","first-page":"270","volume":"18","author":"DL Beekly","year":"2004","unstructured":"Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME et al (2004) The National Alzheimer\u2019s Coordinating Center (NACC) database: an Alzheimer disease database. Alzheimer Dis Assoc Disord 18:270\u2013277","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3100_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK et al (2018) The revised National Alzheimer\u2019s Coordinating Center\u2019s neuropathology form\u2014available data and new analyses. J Neuropathol Exp Neurol 77:717\u2013726. https:\/\/doi.org\/10.1093\/jnen\/nly049","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"key":"3100_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fneur.2018.00589","volume":"9","author":"EW Buczak-Stec","year":"2018","unstructured":"Buczak-Stec EW, Konig HH, Hajek A (2018) Impact of incident Parkinson\u2019s disease on satisfaction with life. Front Neurol 9:589. https:\/\/doi.org\/10.3389\/fneur.2018.00589","journal-title":"Front Neurol"},{"key":"3100_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000218352","author":"Y Chen","year":"2026","unstructured":"Chen Y, Chen A, Power MC, Grodstein F, Kapasi A, Capuano AW et al (2026) Associations of Alzheimer disease and related dementia neuropathologies with timely diagnosis of dementia in healthcare settings. Neurology. https:\/\/doi.org\/10.1212\/wnl.0000000000218352","journal-title":"Neurology"},{"key":"3100_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jnen\/nlac094","volume":"81","author":"DG Coughlin","year":"2022","unstructured":"Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L et al (2022) Digital histological study of neocortical grey and white matter tau burden across tauopathies. J Neuropathol Exp Neurol 81:953\u2013964. https:\/\/doi.org\/10.1093\/jnen\/nlac094","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR15","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/ene.15346","volume":"29","author":"B Couto","year":"2022","unstructured":"Couto B, Martinez\u2010Valbuena I, Lee S, Alfradique\u2010Dunham I, Perrin RJ, Perlmutter JS et al (2022) Protracted course progressive supranuclear palsy. Eur J Neurol 29:2220\u20132231. https:\/\/doi.org\/10.1111\/ene.15346","journal-title":"Eur J Neurol"},{"key":"3100_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/wnl.0000000000002638","volume":"86","author":"ITS Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist ITS, Dick KM, Patterson K, V\u00e1zquez Rodr\u00edquez P, Wehmann E, Wilcox A et al (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743. https:\/\/doi.org\/10.1212\/wnl.0000000000002638","journal-title":"Neurology"},{"key":"3100_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane PK, Gibbons LE, Dams-O\u2019Connor K, Trittschuh E, Leverenz JB, Keene CD et al (2016) Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol 73:1062\u20131069. https:\/\/doi.org\/10.1001\/jamaneurol.2016.1948","journal-title":"JAMA Neurol"},{"key":"3100_CR18","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/bf03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:II6\u2013II15. https:\/\/doi.org\/10.1007\/bf03161076","journal-title":"J Neurol"},{"key":"3100_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jalz.2010.12.004","volume":"7","author":"HH Dodge","year":"2011","unstructured":"Dodge HH, Chang CC, Kamboh IM, Ganguli M (2011) Risk of Alzheimer\u2019s disease incidence attributable to vascular disease in the population. Alzheimers Dement 7:356\u2013360. https:\/\/doi.org\/10.1016\/j.jalz.2010.12.004","journal-title":"Alzheimers Dement"},{"key":"3100_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71511","volume":"22","author":"G Donley","year":"2026","unstructured":"Donley G, Hsiao J, Balintfy J, Silverberg N (2026) Four decades of Alzheimer\u2019s disease discoveries, data, and research resources: the NIH Alzheimer\u2019s Disease Research Center program. Alzheimers Dement 22:e71511. https:\/\/doi.org\/10.1002\/alz.71511","journal-title":"Alzheimers Dement"},{"key":"3100_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/jnen\/nlad025","volume":"82","author":"ED Driver-Dunckley","year":"2023","unstructured":"Driver-Dunckley ED, Zhang N, Serrano GE, Dunckley NA, Sue LI, Shill HA et al (2023) Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy. J Neuropathol Exp Neurol 82:438\u2013451. https:\/\/doi.org\/10.1093\/jnen\/nlad025","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.parkreldis.2011.02.017","volume":"17","author":"VGH Evidente","year":"2011","unstructured":"Evidente VGH, Adler CH, Sabbagh MN, Connor DJ, Hentz JG, Caviness JN et al (2011) Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? Parkinsonism Relat Disord 17:365\u2013371. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.02.017","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70734","volume":"21","author":"DL Fischer","year":"2025","unstructured":"Fischer DL, Grinberg LT, Ahrendsen JT, Beach TG, Bieniek KF, Castellani RJ et al (2025) Celebrating neuropathology\u2019s contributions to Alzheimer\u2019s Disease Research Centers. Alzheimers Dement 21:e70734. https:\/\/doi.org\/10.1002\/alz.70734","journal-title":"Alzheimers Dement"},{"key":"3100_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/alz.13422","volume":"20","author":"K Gauthreaux","year":"2024","unstructured":"Gauthreaux K, Kukull WA, Nelson KB, Mock C, Chen YC, Chan KCG et al (2024) Different cohort, disparate results: selection bias is a key factor in autopsy cohorts. Alzheimers Dement 20:266\u2013277. https:\/\/doi.org\/10.1002\/alz.13422","journal-title":"Alzheimers Dement"},{"key":"3100_CR25","first-page":"49","volume-title":"Progressive supranuclear palsy","author":"N Giagkou","year":"2019","unstructured":"Giagkou N, G\u00fcnter SM (2019) Progressive supranuclear palsy. Elsevier, Amsterdam, pp 49\u201386"},{"key":"3100_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/s0021-9258(18)48531-6","volume":"267","author":"SG Greenberg","year":"1992","unstructured":"Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564\u2013569. https:\/\/doi.org\/10.1016\/s0021-9258(18)48531-6","journal-title":"J Biol Chem"},{"key":"3100_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cjca.2024.12.022","volume":"41","author":"N Grubic","year":"2025","unstructured":"Grubic N, Johnston A, Randhawa VK, Humphries KH, Rosella LC, Maximova K (2025) Breaking down bias: a methodological primer on identifying, evaluating, and mitigating bias in cardiovascular research. Can J Cardiol 41:996\u20131009. https:\/\/doi.org\/10.1016\/j.cjca.2024.12.022","journal-title":"Can J Cardiol"},{"key":"3100_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","volume":"84","author":"M Guasp","year":"2021","unstructured":"Guasp M, Molina-Porcel L, Painous C, Caballol N, Camara A, Perez-Soriano A et al (2021) Association of PSP phenotypes with survival: a brain-bank study. Parkinsonism Relat Disord 84:77\u201381. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.01.015","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115:409\u2013415. https:\/\/doi.org\/10.1007\/s00401-008-0344-8","journal-title":"Acta Neuropathol"},{"key":"3100_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"3100_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Different Tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339\u2013346. https:\/\/doi.org\/10.1159\/000121388","journal-title":"Neurodegener Dis"},{"key":"3100_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.parkreldis.2005.08.007","volume":"12","author":"KA Josephs","year":"2006","unstructured":"Josephs KA, Mandrekar JN, Dickson DW (2006) The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat Disord 12:109\u2013112. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.08.007","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70778","volume":"21","author":"Z Khachaturian","year":"2025","unstructured":"Khachaturian Z (2025) History of Alzheimer\u2019s disease research centers: from inception in 1984 to evolution beyond 2025. Alzheimers Dement 21:e70778. https:\/\/doi.org\/10.1002\/alz.70778","journal-title":"Alzheimers Dement"},{"key":"3100_CR34","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2026.41.e218","volume":"41","author":"SH Kim","year":"2026","unstructured":"Kim SH, Choi E, Cha Y, Hong J, Choi S, Jang SY (2026) Comorbidity trajectories before and after hip fracture in elderly patients: a Korean nationwide database cohort study. J Korean Med Sci 41:e218. https:\/\/doi.org\/10.3346\/jkms.2026.41.e218","journal-title":"J Korean Med Sci"},{"key":"3100_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00622-7","author":"T Koeglsperger","year":"2023","unstructured":"Koeglsperger T, Rumpf S-L, Schlie\u00dfer P, Struebing FL, Brendel M, Levin J et al (2023) Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-023-00622-7","journal-title":"Mol Neurodegener"},{"key":"3100_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s1474-4422(21)00283-0","volume":"20","author":"S Koga","year":"2021","unstructured":"Koga S, Dickson DW, Wszolek ZK (2021) Neuropathology of progressive supranuclear palsy after treatment with tilavonemab. Lancet Neurol 20:786\u2013787. https:\/\/doi.org\/10.1016\/s1474-4422(21)00283-0","journal-title":"Lancet Neurol"},{"key":"3100_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jnen\/nlab005","volume":"80","author":"S Koga","year":"2021","unstructured":"Koga S, Ghayal NB, Dickson DW (2021) Deep learning-based image classification in differentiating tufted astrocytes, astrocytic plaques, and neuritic plaques. J Neuropathol Exp Neurol 80:306\u2013312. https:\/\/doi.org\/10.1093\/jnen\/nlab005","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12759","author":"S Koga","year":"2022","unstructured":"Koga S, Ikeda A, Dickson DW (2022) Deep learning-based model for diagnosing Alzheimer\u2019s disease and tauopathies. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12759","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3100_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/nan.12710","volume":"47","author":"S Koga","year":"2021","unstructured":"Koga S, Zhou X, Dickson DW (2021) Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol 47:931\u2013941. https:\/\/doi.org\/10.1111\/nan.12710","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3100_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106076","volume":"127","author":"R Koizumi","year":"2024","unstructured":"Koizumi R, Akagi A, Riku Y, Miyahara H, Sone J, Tanaka F et al (2024) Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy. Parkinsonism Relat Disord 127:106076. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106076","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol"},{"key":"3100_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bpa.12536","volume":"27","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Lee VM, Trojanowski JQ (2017) Protein astrogliopathies in human neurodegenerative diseases and aging. Brain Pathol 27:675\u2013690. https:\/\/doi.org\/10.1111\/bpa.12536","journal-title":"Brain Pathol"},{"key":"3100_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"3100_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","volume":"126","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Milenkovic I, W\u00f6hrer A, H\u00f6ftberger R, Gelpi E, Haberler C et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365\u2013384. https:\/\/doi.org\/10.1007\/s00401-013-1157-y","journal-title":"Acta Neuropathol"},{"key":"3100_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnen\/nlx007","volume":"76","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA et al (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270\u2013288. https:\/\/doi.org\/10.1093\/jnen\/nlx007","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/alz.12509","volume":"18","author":"JC Lennon","year":"2022","unstructured":"Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM et al (2022) Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 18:1461\u20131471. https:\/\/doi.org\/10.1002\/alz.12509","journal-title":"Alzheimers Dement"},{"key":"3100_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/gps.70252","volume":"41","author":"LY Lin","year":"2026","unstructured":"Lin LY, Wu JS, Jeng WJ, Tsai CH, Liu SY, Huang TW et al (2026) Dementia risk after glaucoma surgery and medical therapy: a multicentre real-world cohort study. Int J Geriatr Psychiatry 41:e70252. https:\/\/doi.org\/10.1002\/gps.70252","journal-title":"Int J Geriatr Psychiatry"},{"key":"3100_CR48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-019-02119-4","volume":"139","author":"H Ling","year":"2020","unstructured":"Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E et al (2020) Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathol 139:717\u2013734. https:\/\/doi.org\/10.1007\/s00401-019-02119-4","journal-title":"Acta Neuropathol"},{"key":"3100_CR49","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1007\/s00415-023-11791-2","volume":"270","author":"S Lyons","year":"2023","unstructured":"Lyons S, Tr\u00e9pel D, Lynch T, Walsh R, O\u2019Dowd S (2023) The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis. J Neurol 270:4451\u20134465. https:\/\/doi.org\/10.1007\/s00415-023-11791-2","journal-title":"J Neurol"},{"key":"3100_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67744-y","author":"I Martinez-Valbuena","year":"2025","unstructured":"Martinez-Valbuena I, Lee S, Santamaria E, Fern\u00e1ndez-Irigoyen J, Forrest SL, Zampar S et al (2025) 4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-67744-y","journal-title":"Nat Commun"},{"key":"3100_CR51","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1212\/wnl.0000000000001595","volume":"84","author":"L Massimo","year":"2015","unstructured":"Massimo L, Zee J, Xie SX, McMillan CT, Rascovsky K, Irwin DJ et al (2015) Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration. Neurology 84:2070\u20132075. https:\/\/doi.org\/10.1212\/wnl.0000000000001595","journal-title":"Neurology"},{"key":"3100_CR52","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Neurology 41:479\u2013479. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"3100_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2174\/156720512801322555","volume":"9","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Sonnen JA, Montine KS, Crane PK, Larson EB (2012) Adult changes in thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. Curr Alzheimer Res 9:718\u2013723. https:\/\/doi.org\/10.2174\/156720512801322555","journal-title":"Curr Alzheimer Res"},{"key":"3100_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0353160","volume":"21","author":"AB Nasir","year":"2026","unstructured":"Nasir AB, Kilani Y, Aldiabat M, Abdelghany O, Hafez Y, Desai N et al (2026) Metabolic risk and metabolic dysfunction\u2013associated steatotic liver disease and steatohepatitis in cognitive decline: a retrospective cohort study. PLoS ONE 21:e0353160. https:\/\/doi.org\/10.1371\/journal.pone.0353160","journal-title":"PLoS ONE"},{"key":"3100_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.hroo.2025.05.020","volume":"6","author":"DM Nelson","year":"2025","unstructured":"Nelson DM, Rowe SJ, Trytell A, Fahy L, Freedman K, Pflaumer A et al (2025) Trends and differences in the rates of autopsy in the United States, 2003 to 2020: a nationwide analysis. Heart Rhythm O2 6:1165\u20131174. https:\/\/doi.org\/10.1016\/j.hroo.2025.05.020","journal-title":"Heart Rhythm O2"},{"key":"3100_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlag035","author":"AM Neltner","year":"2026","unstructured":"Neltner AM, Shahidehpour RK, Hall ME, Ning X, Fister S, Kang H et al (2026) Locus coeruleus TDP-43 pathology in a community-based cohort: clinical and pathological correlates. J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1093\/jnen\/nlag035","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR57","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/nen.0b013e3182768de4","volume":"71","author":"JH Neltner","year":"2012","unstructured":"Neltner JH, Abner EL, Schmitt FA, Denison SK, Anderson S, Patel E et al (2012) Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. J Neuropathol Exp Neurol 71:1075\u20131085. https:\/\/doi.org\/10.1097\/nen.0b013e3182768de4","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1272\/jnms.82.266","volume":"82","author":"A Nogami","year":"2015","unstructured":"Nogami A, Yamazaki M, Saito Y, Hatsuta H, Sakiyama Y, Takao M et al (2015) Early stage of progressive supranuclear palsy: a neuropathological study of 324 consecutive autopsy cases. J Nippon Med Sch 82:266\u2013273. https:\/\/doi.org\/10.1272\/jnms.82.266","journal-title":"J Nippon Med Sch"},{"key":"3100_CR59","doi-asserted-by":"publisher","first-page":"c17","DOI":"10.1159\/000286345","volume":"115","author":"M Noordzij","year":"2010","unstructured":"Noordzij M, Dekker FW, Zoccali C, Jager KJ (2010) Measures of disease frequency: prevalence and incidence. Nephron Clin Pract 115:c17\u2013c20. https:\/\/doi.org\/10.1159\/000286345","journal-title":"Nephron Clin Pract"},{"key":"3100_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae113","author":"F Orlandi","year":"2024","unstructured":"Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL et al (2024) Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcae113","journal-title":"Brain Commun"},{"key":"3100_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01674-y","author":"T Pansuwan","year":"2023","unstructured":"Pansuwan T, Quaegebeur A, Kaalund SS, Hidari E, Briggs M, Rowe JB et al (2023) Accurate digital quantification of tau pathology in progressive supranuclear palsy. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-023-01674-y","journal-title":"Acta Neuropathol Commun"},{"key":"3100_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.27872","volume":"35","author":"G Respondek","year":"2020","unstructured":"Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E et al (2020) Validation of the Movement Disorder Society criteria for the diagnosis of 4\u2010repeat tauopathies. Mov Disord 35:171\u2013176. https:\/\/doi.org\/10.1002\/mds.27872","journal-title":"Mov Disord"},{"key":"3100_CR63","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034","journal-title":"Mov Disord"},{"key":"3100_CR64","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766. https:\/\/doi.org\/10.1002\/mds.26054","journal-title":"Mov Disord"},{"key":"3100_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mdc3.12104","volume":"2","author":"HB Rigby","year":"2015","unstructured":"Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA et al (2015) Clinical features of patients with concomitant Parkinson\u2019s disease and progressive supranuclear palsy pathology. Mov Disord Clin Pract 2:33\u201338. https:\/\/doi.org\/10.1002\/mdc3.12104","journal-title":"Mov Disord Clin Pract"},{"key":"3100_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG et al (2022) Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144:603\u2013614. https:\/\/doi.org\/10.1007\/s00401-022-02479-4","journal-title":"Acta Neuropathol"},{"key":"3100_CR67","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27816","volume":"34","author":"N Sakae","year":"2019","unstructured":"Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ et al (2019) Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Mov Disord 34:1655\u20131662. https:\/\/doi.org\/10.1002\/mds.27816","journal-title":"Mov Disord"},{"key":"3100_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120718","volume":"451","author":"M Sakuwa","year":"2023","unstructured":"Sakuwa M, Adachi T, Suzuki Y, Takigawa H, Hanajima R (2023) Neuropathological analysis of cognitive impairment in progressive supranuclear palsy. J Neurol Sci 451:120718. https:\/\/doi.org\/10.1016\/j.jns.2023.120718","journal-title":"J Neurol Sci"},{"key":"3100_CR69","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00415-011-6205-8","volume":"259","author":"EC Schofield","year":"2012","unstructured":"Schofield EC, Hodges JR, Bak TH, Xuereb JH, Halliday GM (2012) The relationship between clinical and pathological variables in Richardson\u2019s syndrome. J Neurol 259:482\u2013490. https:\/\/doi.org\/10.1007\/s00415-011-6205-8","journal-title":"J Neurol"},{"key":"3100_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70102","author":"RK Shahidehpour","year":"2026","unstructured":"Shahidehpour RK, Neltner AM, Klusty MA, Corbett C, Gonzalez AD, Gutman DA et al (2026) Data-driven thresholds for standardized classification of severe Alzheimer\u2019s disease neuropathology using digital neuropathology. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.70102","journal-title":"Brain Pathol"},{"key":"3100_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2019.10.012","volume":"69","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D et al (2019) Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord 69:34\u201339. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.012","journal-title":"Parkinsonism Relat Disord"},{"key":"3100_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71422","author":"S Shrestha","year":"2026","unstructured":"Shrestha S, Zhu X, Windham BG, Sullivan KJ, Palta P, Gottesman RF et al (2026) Associations of blood biomarkers of glial cell dysfunction and neuronal injury with future cognitive decline and incident dementia. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.71422","journal-title":"Alzheimer's Dement"},{"key":"3100_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/jnen\/nlae009","volume":"83","author":"J Shriram","year":"2024","unstructured":"Shriram J, Malek-Ahmadi M, Irwin C, Sabbagh M (2024) Impact of incidental synucleinopathy in mild cognitive impairment due to Alzheimer disease. J Neuropathol Exp Neurol 83:230\u2013237. https:\/\/doi.org\/10.1093\/jnen\/nlae009","journal-title":"J Neuropathol Exp Neurol"},{"key":"3100_CR74","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/mds.27778","volume":"34","author":"M Stamelou","year":"2019","unstructured":"Stamelou M (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord 34:1087\u20131088. https:\/\/doi.org\/10.1002\/mds.27778","journal-title":"Mov Disord"},{"key":"3100_CR75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele JC (1964) Progressive supranuclear palsy. Arch Neurol 10:333. https:\/\/doi.org\/10.1001\/archneur.1964.00460160003001","journal-title":"Arch Neurol"},{"key":"3100_CR76","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1007\/s00415-023-11629-x","volume":"270","author":"DMA Swallow","year":"2023","unstructured":"Swallow DMA, Counsell CE (2023) The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson\u2019s disease (PD). J Neurol 270:3464\u20133474. https:\/\/doi.org\/10.1007\/s00415-023-11629-x","journal-title":"J Neurol"},{"key":"3100_CR77","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcB U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"3100_CR78","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00702-014-1360-6","volume":"122","author":"DR Thal","year":"2015","unstructured":"Thal DR, Von Arnim CAF, Griffin WST, Mrak RE, Walker L, Attems J et al (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm 122:1007\u20131018. https:\/\/doi.org\/10.1007\/s00702-014-1360-6","journal-title":"J Neural Transm"},{"key":"3100_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-026-13742-z","author":"SKS Ting","year":"2026","unstructured":"Ting SKS, Asahara Thio S, Cao K, Hameed S, Li W, Mukesh Shah J et al (2026) Early clinical characteristics of pathologically confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. https:\/\/doi.org\/10.1007\/s00415-026-13742-z","journal-title":"J Neurol"},{"key":"3100_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14283\/jpad.2022.81","volume":"10","author":"AY Wang","year":"2023","unstructured":"Wang AY, Hu HY, Ou YN, Wang ZT, Ma YH, Tan L et al (2023) Socioeconomic status and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 39 prospective studies. J Prev Alzheimers Dis 10:83\u201394. https:\/\/doi.org\/10.14283\/jpad.2022.81","journal-title":"J Prev Alzheimers Dis"},{"key":"3100_CR81","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/brain\/awaf351","volume":"149","author":"DJ Whiteside","year":"2026","unstructured":"Whiteside DJ, Rouse MA, Jones PS, Coyle-Gilchrist I, Murley AG, Stockton K et al (2026) The presymptomatic and early manifestations of semantic dementia. Brain 149:1663\u20131678. https:\/\/doi.org\/10.1093\/brain\/awaf351","journal-title":"Brain"},{"key":"3100_CR82","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, De Silva R, Paviour DC, Pittman A, Watt HC, Kilford L et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128:1247\u20131258. https:\/\/doi.org\/10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"3100_CR83","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, De Silva R, Lees AJ et al (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130:1566\u20131576. https:\/\/doi.org\/10.1093\/brain\/awm104","journal-title":"Brain"},{"key":"3100_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(92)90145-w","volume":"135","author":"T Yamada","year":"1992","unstructured":"Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135:99\u2013102. https:\/\/doi.org\/10.1016\/0304-3940(92)90145-w","journal-title":"Neurosci Lett"},{"key":"3100_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1893517","volume":"13","author":"W Yang","year":"2026","unstructured":"Yang W, Chen Z, Zhang Y, Peng C, Chen B (2026) Flavonoid-rich dietary patterns and incident hospital-recorded Parkinson\u2019s disease: a prospective UK Biobank study. Front Nutr 13:1893517. https:\/\/doi.org\/10.3389\/fnut.2026.1893517","journal-title":"Front Nutr"},{"key":"3100_CR86","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-016-1665-7","volume":"133","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809\u2013823. https:\/\/doi.org\/10.1007\/s00401-016-1665-7","journal-title":"Acta Neuropathol"},{"key":"3100_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-6-2","author":"J Zaccai","year":"2006","unstructured":"Zaccai J, Ince P, Brayne C (2006) Population-based neuropathological studies of dementia: design, methods and areas of investigation\u2014a systematic review. BMC Neurol. https:\/\/doi.org\/10.1186\/1471-2377-6-2","journal-title":"BMC Neurol"},{"key":"3100_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70272","author":"X Zhou","year":"2026","unstructured":"Zhou X, Zhang G, Hu Q, Shao H, Yang T, Wang J et al (2026) Association of excessive daytime sleepiness with long-term incident dementia: the role of \u03b2-Amyloid and white matter injury. Alzheimer\u2019s Dement: Trans Res Clin Intervent. https:\/\/doi.org\/10.1002\/trc2.70272","journal-title":"Alzheimer's Dement: Trans Res Clin Intervent"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03100-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03100-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03100-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:02:40Z","timestamp":1791936160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03100-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3100"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03100-8","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest (or competing interests) with respect to the research, authorship, and\/or publication of this article. Corresponding author Dr. Peter Nelson and coauthor Dr. Gabor Kovacs are members of the\n                      Acta Neuropathologica\n                      Editorial Board but neither played a role nor had any input in the manuscript review.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ADRCs use protocols including autopsy and recruitment informed consent forms that were approved by their local Institutional Review Boards (IRBs). Informed consent was obtained from UK-ADRC research participants (and\/or their legally authorized representatives) as stipulated in University of Kentucky IRB #44009.","order":2,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}